News & Events
People diagnosed with CIS who received early treatment are less likely to convert to MS
Optical coherence tomography may be used to test the effect of drugs in relapsing-remitting MS trials
Some family members of people with MS show possible early signs of the disease without symptoms
A biomarker in cerebrospinal fluid is associated with a higher risk of MS in people with CIS
The 7th All-Russian Congress of patients was held in Moscow and attended by over 424 delegates
National Multiple Sclerosis Day marked across Portugal
Further evidence shows the role of vitamin D in MS risk, especially during pregnancy
250 people with progressive MS are taking part in the SPRINT-MS trial for ibudilast
Professor Alan Thompson highlights some of 2016’s research discoveries in MS
Issue 17: 11 organisations from the Arab region share their news
‘Young people beyond MS’
A new study fails to replicate the role of a gene in developing primary progressive MS